RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akira Kawamura to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Akira Kawamura has written about Lung Neoplasms.
Akira Kawamura
Connection Strength
0.352
Lung Neoplasms
  1. Kariya M, Yamamoto K, Kawamura A, Tanizaki S, Ueda K, Sai K, Hata A. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study. Support Care Cancer. 2024 Jun 03; 32(6):400.
    View in: PubMed
    Score: 0.177
  2. Harada E, Yoshida S, Imaizumi Y, Kawamura A, Ohtsuka T, Yoshida K. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma. Biochim Biophys Acta Gen Subj. 2024 Jun; 1868(6):130600.
    View in: PubMed
    Score: 0.174
  3. Ito Y, Takahashi T, Kawamura A, Tu SM. High anti-EB virus titer in sera of patients with nasopharyngeal carcinoma: a small-scaled seroepidemiological study. Gan. 1969 Jun; 60(3):335-40.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support